iBio tech is offering two services. The services are the development of therapeutics and the development of diagnostics kits.
iBio tech propose a unique novel nanoconjugate that will specifically target and clear the pro-inflammatory autoantibodies.
iBio tech is also working on the research and development of an amplification-free genotyping platform.
The diagnostic method offers an earlier diagnostic which means less permanent disability due to autoimmune diseases and milder treatment options.